Eberhard Grambow1, Michael Dau2, Niels Arne Sandkühler1, Matthias Leuchter1, Amadeus Holmer3, Ernst Klar1, Malte Weinrich1. 1. Department for General, Visceral, Vascular and Transplantation Surgery, University Medical Center Rostock, Rostock, Germany. 2. Department of Oral, Maxillofacial and Plastic Surgery, University Medical Center Rostock, Rostock, Germany. 3. Diaspective Vision GmbH, Am Salzhaff, Germany.
Abstract
BACKGROUND: Objective, reliable and easy screening for peripheral artery disease (PAD) is essential to confirm the diagnosis and initiate the respective treatment. Therefore, a new non-invasive hyperspectral camera (TIVITA® Tissue) was tested in patients with and without PAD. OBJECTIVE: It was hypothesized that the oxygenation parameters of the TIVITA® Tissue correlate to established modalities for detection of PAD and allow differentiation between individuals with and without PAD. METHODS: Evaluation of tissue oxygenation was performed in the angiosome of the medial plantar artery in 25 healthy young people and in 24 patients with and 25 patients without PAD in comparable age. Thereby, superficial oxygenation (StO2) and near-infrared (NIR) perfusion index were measured with the TIVITA® Tissue. Additionally, the ankle-brachial-index (ABI), the complaint free walking distance and the vascular quality of life were assessed and demographic data were obtained from all participants. RESULTS: TIVITA® Tissue analysis revealed significantly reduced StO2 and NIR perfusion index in PAD compared to healthy young participants and patients without PAD. StO2 and NIR perfusion index positively correlated with ABI, the complaint free walking distance and the vascular quality of life score. CONCLUSIONS: In summary, this new hyperspectral imaging camera bears great potential for PAD screening as well as for follow up.
BACKGROUND: Objective, reliable and easy screening for peripheral artery disease (PAD) is essential to confirm the diagnosis and initiate the respective treatment. Therefore, a new non-invasive hyperspectral camera (TIVITA® Tissue) was tested in patients with and without PAD. OBJECTIVE: It was hypothesized that the oxygenation parameters of the TIVITA® Tissue correlate to established modalities for detection of PAD and allow differentiation between individuals with and without PAD. METHODS: Evaluation of tissue oxygenation was performed in the angiosome of the medial plantar artery in 25 healthy young people and in 24 patients with and 25 patients without PAD in comparable age. Thereby, superficial oxygenation (StO2) and near-infrared (NIR) perfusion index were measured with the TIVITA® Tissue. Additionally, the ankle-brachial-index (ABI), the complaint free walking distance and the vascular quality of life were assessed and demographic data were obtained from all participants. RESULTS: TIVITA® Tissue analysis revealed significantly reduced StO2 and NIR perfusion index in PAD compared to healthy young participants and patients without PAD. StO2 and NIR perfusion index positively correlated with ABI, the complaint free walking distance and the vascular quality of life score. CONCLUSIONS: In summary, this new hyperspectral imaging camera bears great potential for PAD screening as well as for follow up.
Entities:
Keywords:
Hyperspectral imaging; perfusion imaging; screening; skin microcirculation; vascular surgery
Authors: Alexander Studier-Fischer; Silvia Seidlitz; Jan Sellner; Berkin Özdemir; Manuel Wiesenfarth; Leonardo Ayala; Jan Odenthal; Samuel Knödler; Karl Friedrich Kowalewski; Caelan Max Haney; Isabella Camplisson; Maximilian Dietrich; Karsten Schmidt; Gabriel Alexander Salg; Hannes Götz Kenngott; Tim Julian Adler; Nicholas Schreck; Annette Kopp-Schneider; Klaus Maier-Hein; Lena Maier-Hein; Beat Peter Müller-Stich; Felix Nickel Journal: Sci Rep Date: 2022-06-30 Impact factor: 4.996
Authors: Max Kistler; Hannes Köhler; Jan Theopold; Ines Gockel; Andreas Roth; Pierre Hepp; Georg Osterhoff Journal: Sci Rep Date: 2022-01-12 Impact factor: 4.379
Authors: Eberhard Grambow; Niels Arne Sandkühler; Justus Groß; Daniel G E Thiem; Michael Dau; Matthias Leuchter; Malte Weinrich Journal: J Clin Med Date: 2022-01-30 Impact factor: 4.241
Authors: Simone F Kleiss; Kirsten F Ma; Mostafa El Moumni; Richte C L Schuurmann; Clark J Zeebregts; Marieke Haalboom; Reinoud P H Bokkers; Jean-Paul P M de Vries Journal: J Clin Monit Comput Date: 2021-04-12 Impact factor: 1.977